Ocaratuzumab (Anti-CD20)
Product Specifications
CAS Number
1169956-08-4
Synonyms
AME 133v, LY 2469298
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Ocaratuzumab (anti-CD20) is a Fc-engineered monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC) . MW: 145.38 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740276-100 1x 100 µL
TAG-72 / CA72.4 (B72.3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741081-100 1x 100 µL
CD45RO (190-2F2.5), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880009-100 1x 100 µL
MART-1 / Melan-A (M2-7C10), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941917-100 1x 100 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (rCHGA/798), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880714-100 1x 100 µL
Thymidylate Synthase (TS106), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details